Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ KAO Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA583175
Description
Immunogen sequence: TKPLHQFFLN TTGFSFQDCH DRCLAFTDVA PRGVASGQRR SWLIIQRYVE GYFLHPTGLE LLVDHGSTDA GHWA.
This gene encodes a metal-binding membrane glycoprotein that oxidatively deaminates putrescine, histamine, and related compounds. The encoded protein is inhibited by amiloride, a diuretic that acts by closing epithelial sodium ion channels. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
Specifications
KAO | |
Polyclonal | |
Unconjugated | |
AOC1 | |
1600012D06Rik; Abp; abp1; amiloride binding protein 1 (amine oxidase (copper-containing)); amiloride binding protein 1 (amine oxidase, copper-containing); amiloride binding protein/diamine oxidase; amiloride-binding protein 1; amiloride-sensitive amine oxidase; amiloride-sensitive amine oxidase [copper-containing]; amine oxidase copper containing 1; Amine oxidase copper domain-containing protein 1; amine oxidase, copper containing 1; amine oxidase, copper-containing 1; aoc1; DAO; DAO1; Diamine oxidase; histaminase; KAO; kidney amine oxidase; si:ch211-286c5.2; zgc:154101 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
26 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
P19801 | |
AOC1 | |
Recombinant protein corresponding to Human AOC1. Recombinant protein control fragment (Product #RP-94962). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Safety and Handling
WARNING: Cancer - www.P65Warnings.ca.gov
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction